eXoZymes Inc.

Stage 1 · Basing · week 2

As of Oct 22, 2026, eXoZymes is in Stage 1, the basing phase, now in week 2 (since Oct 13, 2026). It closed at $3.90, 76.4% below its 52-week high and below its 200-day average, which is falling.

eXoZymes, Inc. operates as a development stage biotechnology company. More about the company

$3.90

-0.51% today

$36.3M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Steady

Edge

—

Is EXOZ early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-11-13 → 2026-10-22

S? 42w

S4 12w

S4 16w

2024-11-132026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 2w → S1 7w → S2 8w → S3 6w → S4 12w → S1 7w → S4 16w → S1 1w current

Total tracked: 101 weeks across 9 stage runs.

EXOZ among Biotechnology433rd of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…433	EXOZeXoZymes Inc.	Stage 1 · wk 2	15	−38.9%

vs 52W High

-76.4%

$3.90 lo$16.50 hi

76.4% below 52W high

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 2

1w13w26w

Week 2, early base

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

-50.9%

200 DMA: $7.94 · sloping down

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

3.31x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-38.9%

-17.2%

-62.2%

YTD

-64.5%

-69.0%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S1

Wk 2 · Vol 3.31x

2026-10-21S1

Wk 2 · Vol 2.52x

2026-10-20S1

Wk 2 · Vol 0.56x

2026-10-19S1

Wk 1 · Vol 1.17x

2026-10-16S1

Wk 1 · Vol 4.60x

2026-10-15S1

Wk 1 · Vol 3.66x

2026-10-14S1

Wk 1 · Vol 1.15x

2026-10-13S14→1

Wk 1 · Vol 3.21x

2026-10-12S4

Wk 16 · Vol 1.50x

2026-10-09S4

Wk 15 · Vol 0.16x

2026-10-08S4

Wk 15 · Vol 3.67x

2026-10-07S4

Wk 15 · Vol 1.27x

Moving averages & range

50 DMA

$5.95

200 DMA

$7.94

52W High

$16.50

52W Low

$3.90

5D Low

$3.90

Resistance levels (recent highs)

20d High

$6.25

60d High

$7.53

120d High

$10.54

250d High

$16.50

Next resistance

+60.1%

to 20d High

ROE

-187.2%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 9.9

eXoZymes: quick answers

What stage is eXoZymes in?

As of Oct 22, 2026, eXoZymes (EXOZ) is in Stage 1, the basing phase. It entered Stage 1 on Oct 13, 2026 and is in week 2. What the four stages mean

Is eXoZymes in an uptrend?

Not yet. eXoZymes is in Stage 1, a base that can come before an uptrend. It trades 50.9% below its 200-day average, which is falling.

How far is eXoZymes from its 52-week high?

eXoZymes closed at $3.90 on Oct 22, 2026, 76.4% below its 52-week high of $16.50. Its 52-week low is $3.90.

How has eXoZymes performed over the past year?

As of Oct 22, 2026, eXoZymes is down 69.0% over the past year and down 64.5% so far in 2026.

Which sector and industry is eXoZymes in?

eXoZymes is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.